Cell therapy approaches to autism: a review of clinical trial data

Area of Science:

• Neuroscience
• Regenerative Medicine
• Developmental Pediatrics

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition.
• Cell therapies are being explored as a potential treatment for ASD.
• Several clinical trials have investigated the efficacy of cell therapies for ASD.

Purpose of the Study:

• To review and evaluate the outcomes of published clinical trials on cell therapies for ASD.
• To identify limitations and challenges in the current therapeutic approaches.
• To propose recommendations for future research and development in this field.

Main Methods:

• Systematic review of published clinical trial data for cell therapies in ASD.
• Critical analysis of study designs, therapeutic targets, and reported outcomes.
• Identification of common deficiencies and areas for improvement.

Main Results:

• Published trials for cell therapies in ASD are limited in number.
• Current studies often lack clearly identified therapeutic targets.
• Deficiencies exist in the therapeutic strategies and patient stratification.
• Reported outcomes show variable success, necessitating further investigation.

Conclusions:

• The current evidence base for cell therapies in ASD is preliminary.
• Significant improvements are needed in preclinical research, including patient stratification and biomarker identification.
• Further studies should focus on defining the mode of action and optimizing cell preparation and characterization for enhanced therapeutic efficacy.